Pfizer Reports Second-Quarter 2013 Results | Pfizer Pharmaceutical News and Media | Pfizer: the world’s largest research-based pharmaceutical company


Pfizer Reports Second-Quarter 2013 ResultsResults Reflect the Animal Health Business (Zoetis(1)) as a Discontinued Operation for Second-Quarter and Year-to-Date 2013 and 2012Second-Quarter 2013 Revenues of $13.0 Billion, Adjusted Diluted EPS(2) of $0.56 and Reported Diluted EPS(3) of $1.98Repurchased $3.3 Billion and $8.7 Billion of Common Stock in Second-Quarter and to Date in 2013, RespectivelyAccepted 405.1 Million Shares of Common Stock in Exchange for Remaining Zoetis(1) InterestReaffirmed All Components of Adjusted Financial GuidanceAnnounced Plan to Create Separate, Internal, Global Innovative and Value Businesses Tuesday, July 30, 2013 3:49 am EDT

See on

From Pharmaceutical Industry digital vision


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s